Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06220344Phase 3Completed
A Phase 3 trial of Revamil in surgical site infection (SSI), sponsored by HITEC Institute of Medical Sciences. Started Dec 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06220344.